Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(AEL, CLNO, PWRM, AEO, ACW) Notable Stock by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

American Equity Investment Life Holding Company (NYSE:AEL) announced that it will release second quarter 2011 earnings after the close of market on Wednesday, August 3, 2011. The second quarter earnings release and financial supplement will be posted on the American Equity web site (www.american-equity.com) at that time. EL will hold a conference call to discuss second quarter 2011 earnings on Thursday, August 4, 2011, at 10 a.m. CDT. The conference call will be webcast live on the Internet. Investors and interested parties who wish to listen to the call on the Internet may do so at www.american-equity.com.

American Equity Investment Life Holding Company, through its wholly-owned operating subsidiaries, is a full service underwriter of annuity and life insurance products, with a primary emphasis on the sale of index and fixed rate annuities. The company's headquarters are located at 6000 Westown Parkway, West Des Moines, Iowa, 50266. The mailing address of the company is: P.O. Box 71216, Des Moines, Iowa 50325.

*****************

http://pennyomega.com/img/clno.jpg Cleantech Transit Inc. (OTCPK:CLNO)

Biomass is biological matter that is acquired from plants and animals and has large amounts of carbon as well as traces of oxygen, nitrogen, hydrogen, alkaline earth and heavy metals in it. One of the main advantages of biomass is that it is a renewable source of energy (it can be easily replaced). The main sources that are used to formulate biomass are wood, alcohol fuels and solid waste. These would include things like fallen branches and leaves (of the forest), dead plants, wood waste from paper and pulp, domestic waste, Municipal Solid Waste (NASDAQ:MSW), recyclable waste, ethanol and others

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

Cleantech Transit, Inc. (OTCPK:CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.

*************************

power3 Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Alzheimer's disease is a brain disorder that destroys our ability to learn, remember, communicate, and function in our daily lives. It affects 4.5 million people in the United States alone. A type of dementia, Alzheimer's disease destroys the nerve cells in the brain, preventing information from being relayed accurately to the body. Alzheimer's disease is a progressive disorder that will gradually worsen over time; there are numerous stages of Alzheimer.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

*****************

American Eagle Outfitters, Inc. (NYSE:AEO) announced a quarterly cash dividend of $0.11 per share, marketing the company's 28th consecutive quarterly dividend. The dividend was declared on June 21, 2011 and is payable on July 22, 2011 to stockholders of record at the close of business on July 8, 2011.

American Eagle Outfitters, Inc. operates as an apparel and accessories retailer in the United States and Canada. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

*****************

Accuride Corporation (NYSE:ACW) announced that it has acquired substantially all of the assets of Forgitron Technologies LLC, a portfolio company of Kamylon Capital. These assets include an 80,000-square-foot forged aluminum wheel manufacturing facility located in Camden, South Carolina. Accuride plans to convert the production of the facility to Accuride-branded aluminum wheels for the commercial vehicle market.

Accuride Corporation is one of the largest and most diversified manufacturers and suppliers of commercial vehicle components in North America.For more information, visit Accuride's website at
http://www.accuridecorp.com.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg